Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for Angina in Unrevascularized CAD
NCT02265796Phase 2Completed
- Sponsor
- North Florida Foundation for Research and Education
- Start
- Sep 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in angina pectoris, sponsored by North Florida Foundation for Research and Education. Started Sep 2014; status: completed.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02265796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02265796.